We are live on ! Find out more
NGM

North Growth Management Portfolio holdings

AUM $780M
1-Year Est. Return 102.77%
This Fund
S&P 500
This Quarter Est. Return
-18.56%
1 Year Est. Return
+102.77%
3 Year Est. Return
+230.6%
5 Year Est. Return
+253.58%
10 Year Est. Return
AUM
$431M
AUM Growth
-$110M
Cap. Flow
-$6.52M
Cap. Flow %
-1.51%
Top 10 Hldgs %
39.77%
Holding
59
New
8
Increased
11
Reduced
6
Closed
12

Top Buys

Rank Stock Value
1
CPRI icon
Capri Holdings
CPRI
+$10.4M
2
FISV
Fiserv Inc
FISV
+$9.8M
3
WBD icon
Warner Bros
WBD
+$8.27M
4
TMO icon
Thermo Fisher Scientific
TMO
+$7.71M
5
CROX icon
Crocs
CROX
+$5.95M

Top Sells

Rank Stock Value
1
TPR icon
Tapestry
TPR
+$11.9M
2
GPN icon
Global Payments
GPN
+$9.97M
3
RVTY icon
Revvity
RVTY
+$8.98M
4
EBAY icon
eBay
EBAY
+$8.43M
5
DIS icon
Walt Disney
DIS
+$7.08M

Sector Composition

Rank Sector Weight
1 Technology 43.89%
2 Consumer Discretionary 19.81%
3 Healthcare 19.33%
4 Industrials 12.98%
5 Communication Services 3.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CIEN icon
1
Ciena
CIEN
$53.6B
$22.6M 5.24%
494,000
JBL icon
2
Jabil
JBL
$31.6B
$19.8M 4.59%
387,000
BMY icon
3
Bristol-Myers Squibb
BMY
$136B
$19.6M 4.55%
255,000
QCOM icon
4
Qualcomm
QCOM
$175B
$17.6M 4.08%
138,000
HPQ icon
5
HP
HPQ
$27.5B
$16.4M 3.8%
501,000
LITE icon
6
Lumentum
LITE
$80.3B
$16.3M 3.78%
205,000
-29,000
-12% -$2.48M
COHR icon
7
Coherent
COHR
$54.7B
$15.6M 3.63%
307,000
ELV icon
8
Elevance Health
ELV
$85.5B
$15.4M 3.57%
32,000
-7,000
-18% -$3.46M
SEDG icon
9
SolarEdge
SEDG
$1.93B
$14.4M 3.34%
53,000
AMAT icon
10
Applied Materials
AMAT
$366B
$13.8M 3.19%
151,000
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$12.7M 2.94%
159,000
+38,000
+31% +$3.6M
DHI icon
12
D.R. Horton
DHI
$41.2B
$12.6M 2.93%
191,000
MSI icon
13
Motorola Solutions
MSI
$80.4B
$12.4M 2.89%
59,000
J icon
14
Jacobs Solutions
J
$17.8B
$12.3M 2.86%
117,270
FDX icon
15
FedEx
FDX
$78.3B
$12.1M 2.79%
53,000
-6,000
-10% -$1.28M
RH icon
16
RH
RH
$2.83B
$10.6M 2.46%
50,000
+19,000
+61% +$5.64M
SYNH
17
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$10.2M 2.37%
142,000
+33,000
+30% +$2.41M
WBD icon
18
Warner Bros
WBD
$72.1B
$9.23M 2.14%
688,000
+446,000
+184% +$8.27M
CPRI icon
19
Capri Holdings
CPRI
$1.53B
$9.17M 2.13%
+224,000
New +$10.4M
FISV
20
Fiserv Inc
FISV
$28.3B
$8.99M 2.09%
+101,000
New +$9.8M
FNKO icon
21
Funko
FNKO
$398M
$8.85M 2.05%
397,000
+127,000
+47% +$2.46M
BBY icon
22
Best Buy
BBY
$17.4B
$8.81M 2.04%
135,000
-18,000
-12% -$1.5M
NVDA icon
23
NVIDIA
NVDA
$5.25T
$8.27M 1.92%
550,000
+120,000
+28% +$2.26M
SGI
24
Somnigroup International
SGI
$13.5B
$8.05M 1.87%
377,000
JCI icon
25
Johnson Controls International
JCI
$84.6B
$8.01M 1.86%
167,000

Similar funds

North Growth Management's Q2 2022 Portfolio in Review

As of Q2 2022, North Growth Management held 59 positions worth $431M, down 20% from $541M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

North Growth Management's Q2 2022 filing shows 8 new, 11 increased, 6 reduced and 12 closed positions. Its largest new stake was Capri Holdings: 224,000 shares worth $9.17M. The largest sale was Tapestry, an estimated $11.9M.

By sector, the portfolio is most concentrated in Technology at 44% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • North Growth Management's largest Q2 2022 buy was Capri Holdings: 224,000 shares worth $9.17M.
  • North Growth Management added most to Warner Bros in Q2 2022, an estimated $8.27M increase.
  • North Growth Management's biggest Q2 2022 reduction was Foot Locker, cutting an estimated $4.66M.
  • North Growth Management fully exited Tapestry in Q2 2022, selling an estimated $11.9M.
  • North Growth Management's ten largest holdings make up 40% of its $431M portfolio in Q2 2022.
  • North Growth Management opened 8 new positions and closed 12 in Q2 2022.
  • North Growth Management's portfolio value fell 20% quarter-over-quarter to $431M.

Based on North Growth Management's 13F filing for Q2 2022, filed 18 Jul 2022.